Information:
Error:
ID
4740
Description
1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy see http://clinicaltrials.gov/ct2/show/study/NCT00153023
Link
http://clinicaltrials.gov/ct2/show/study/NCT00153023
Keywords
Versions (2)
- 11/22/11 11/22/11 -
- 3/25/14 3/25/14 - Martin Dugas
Uploaded on
March 25, 2014
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility NCT00153023 Type 2 diabetes mellitus
Eligibility Hypertension and Diabetes NCT00153023
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension and Diabetes NCT00153023
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age
Item
30 to 80 Years
boolean
C0001779 (UMLS CUI-1)
Type 2 Diabetes mellitus
Item
Type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI-1)
Hypertension
Item
Hypertension at screening defined as: an average cuff systolic blood pressure > 130 mmHg and/or diastolic blood pressure >80 mmHg in untreated patients OR patients receiving antihypertensive therapy (i.e., medications specifically prescribed to treat hypertension)
boolean
C0020538 (UMLS CUI-1)
Nephropathy
Item
Overt nephropathy defined by 24 hour proteinuria >= 900 mg and by serum creatinine below 265 mol/l (3.0 mg/dl)
boolean
CL415397 (UMLS CUI-1)
C0033687 (UMLS CUI-2)
C0201976 (UMLS CUI-3)
C0033687 (UMLS CUI-2)
C0201976 (UMLS CUI-3)